VRAP Vranken-Pommery Monopole SA

VRANKEN-POMMERY MONOPOLE : nombre total de droits de vote et d'actions au 30.09.2020

VRANKEN-POMMERY MONOPOLE : nombre total de droits de vote et d'actions au 30.09.2020
EN
07/10/2020

Underlying

VRAPVranken-Pommery Monopole SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Vranken-Pommery Monopole SA

Jean-François Granjon ... (+3)
  • Jean-François Granjon
  • Louis Boujard
  • CFA
AUTN AUTONEUM HOLDING AG
EVT EVOTEC SE
PHA PHARMAGEST INTERACTIVE SA
ALDEL DELFINGEN INDUSTRY SA
OERL OC OERLIKON CORPORATION AG
VRAP VRANKEN-POMMERY MONOPOLE SA
NOEJ NORMA GROUP SE
POS PORR AG
ADN1 ADESSO AG
ALBFR SIDETRADE SA
SMHN SUESS MICROTEC AG
CSM CORBION NV
WPL WIRTUALNA POLSKA HOLDING SA
DMP DERMAPHARM HOLDING SE
ATRY ATRYS HEALTH
S30 SOLUTIONS 30 SE
KTA KNAUS TABBERT
LHYFE LHYFE S.A.
CO CASINO GUICHARD-PERRACHON
03/31/26 March 31, 2026 1 EN
Jean-François Granjon ... (+3)
  • Jean-François Granjon
  • Louis Boujard
  • CFA
AUTN AUTONEUM HOLDING AG
EVT EVOTEC SE
PHA PHARMAGEST INTERACTIVE SA
ALDEL DELFINGEN INDUSTRY SA
OERL OC OERLIKON CORPORATION AG
VRAP VRANKEN-POMMERY MONOPOLE SA
VETO VETOQUINOL SA
NOEJ NORMA GROUP SE
POS PORR AG
ADN1 ADESSO AG
ALBFR SIDETRADE SA
SMHN SUESS MICROTEC AG
CSM CORBION NV
WPL WIRTUALNA POLSKA HOLDING SA
DMP DERMAPHARM HOLDING SE
ATRY ATRYS HEALTH
S30 SOLUTIONS 30 SE
KTA KNAUS TABBERT
LHYFE LHYFE S.A.
CO CASINO GUICHARD-PERRACHON
03/31/26 March 31, 2026 1 FR
Fatma Agnès Hamdani
  • Fatma Agnès Hamdani
VRAP VRANKEN-POMMERY MONOPOLE SA
03/31/26 March 31, 2026 1 EN
Fatma Agnès Hamdani
  • Fatma Agnès Hamdani
VRAP VRANKEN-POMMERY MONOPOLE SA
03/31/26 March 31, 2026 1 FR
 PRESS RELEASE
Free
VRAP Vranken-Pommery...

Maison Pommery & Associés - Annual results 2025

Maison Pommery & Associés - Annual results 2025 Financial Press Release : Annual results 2025   Reims, March 30, 2026 The Board of Directors of Maison Pommery & Associés met on March 30, 2026, under the chairmanship of Mr. Paul François Vranken, and in the presence of the Statutory Auditors, to approve the Group’s financial statements for the 2025 fiscal year. Consolidated data31/12/2025*(M€)31/12/2024(M€)Change(M€)Change(%)Turnover293.2304.0-10.8-3.6%Current Operating Income20.035.7-15.7-44.1%Operating Income64.135.1+29.0+82.5%Financial Result-32.6-33.5-0.9 Net Income31.90.8+31.0+3751.9...

March 30, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch